Vericel (VCEL) Amortizatization of Intangibles (2018 - 2026)
Vericel (VCEL) reported Amortizatization of Intangibles of $27000.0 for Q1 2026, down 77.31% on a YoY basis from $119000.0 in Q1 2025, and up 145.76% sequentially from -$59000.0 in Q4 2025.
Vericel (VCEL) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Vericel (VCEL) has 9 years of Amortizatization of Intangibles data on file, last reported at $27000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 77.31% year-over-year to $27000.0; the trailing twelve-month figure through Mar 2026 stood at $91000.0 (down 86.5% YoY), and the FY2025 full-year result was $183000.0, down 72.15% from the prior year.
- Amortizatization of Intangibles climbed to $27000.0 in Q1 2026, from -$59000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $290000.0 in Q1 2023 to a low of -$194000.0 in Q1 2022.
- A 5-year average of $93176.5 and a median of $102000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles jumped 9566.67% in 2023 and slumped 151.3% in 2025, its largest moves.
- Tracing VCEL's Amortizatization of Intangibles over 5 years: stood at $198000.0 in 2022, then tumbled by 81.82% to $36000.0 in 2023, then surged by 219.44% to $115000.0 in 2024, then tumbled by 151.3% to -$59000.0 in 2025, then jumped by 145.76% to $27000.0 in 2026.
- Business Quant data shows VCEL's Amortizatization of Intangibles at $27000.0 in Q1 2026, -$59000.0 in Q4 2025, and $70000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Vericel | 2.33 Bn | 2.18 Bn | 49.27 Mn | 27,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | -59,000.00 |
| Dec 31, 2025 | -59,000.00 |
| Sep 30, 2025 | 70,000.00 |
| Sep 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Sep 30, 2024 | 177,000.00 |
| Sep 30, 2024 | 177,000.00 |
| Jun 30, 2024 | 263,000.00 |
| Jun 30, 2024 | 263,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Dec 31, 2023 | 36,000.00 |
| Dec 31, 2023 | 36,000.00 |